A Neutrophil Activation Biomarker Panel in Prognosis and Monitoring of Patients With Rheumatoid Arthritis.

Mary BachJeonghun MoonRichard MooreTiffany PanJ Lee NelsonChristian Lood

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2019)

Neutrophils undergo marked activation and cell death in RA. Neutrophil biomarkers can provide added clinical value in the monitoring and prognosis of RA patients and may allow for early preventive treatment intervention.

Keyphrases

cell death
rheumatoid arthritis
end stage renal disease
randomized controlled trial
ejection fraction
newly diagnosed
prognostic factors
disease activity
ankylosing spondylitis
systemic lupus erythematosus
interstitial lung disease
cell proliferation
patient reported outcomes
systemic sclerosis
patient reported